Abstract
In many ways, pelvic inflammatory disease (PID) is a behavioral disease: its etiology involves the interaction of microorganisms with individual behavior, and its prevention and control require individual behavior change, including appropriate actions of clinicians and public health professionals. Our goal in this chapter is to examine the role of such behavior—of individuals, communities, and health-care providers—in the complex pathogen-esis of PID and its sequelae. We will examine behavioral risk for PID in the context of the normal physiology and microbiology of the female genital tract, the different microorganisms that give rise to lower genital tract infection, and factors related to the ascendance of bacteria to the upper genital tract. In particular, we will focus on those behaviors that suggest interventions to reduce PID morbidity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Paavonen J, Teisala K, Heinonnen PK, et al. Microbiological and histological findings in acute pelvic inflammatory disease. Br J Obstet Gynecol 1987; 94:454.
Weström L, Mardh P-A. Acute pelvic inflammatory disease, in Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ (eds): Sexually Transmitted Diseases, 2nd ed. New York, McGraw-Hill International Book Co., 1990, pp 593–613.
Faro S, Martens M, Maccato M, Hammill H, Pearlman M. Vaginal flora and pelvic inflammatory disease. Am J Obstet Gynecol 1993;169:470–474.
Rice PA, Schachter J. Pathogenesis of pelvic inflammatory disease: What are the questions? JAMA 1991;266:2587–2593.
Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev 1991;4:485–502.
Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H202-generating lactobacilli. J Infect Dis 1991;164:94–100.
Hughes VL, Hillier SL. Microbiologic characteristics of lactobacillus products used for colonization of the vagina. Obstet Gynecol 1990;75:244–248.
Hillier S. The vagina as an ecosystem. Presented at the International Society of STD Research 9th International Meeting. Banff, Alberta, Canada, Oct. 6-9, 1991.
Holmes KK. Lower genital tract infections in women: Cystitis, urethritis, vulvovaginitis, and cervicitis, in Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ (eds): Sexually Transmitted Diseases, 2nd ed. New York, McGraw-Hill International Book Co., 1990, pp 527–545.
Weström L, Wølner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993;69:9–17.
Keith LG, Berger GS, Edelman DA, et al. On the causation of pelvic inflammatory disease. Am J Obstet Gynecol 1984;149:215–223.
Fox CH, Wolff HS, Baker JA. Measurement of intravaginal and intrauterine pressures during human coitus by radio-telemetry. J Reprod Fertil 1970; 22:243–251.
Aral SO, Mosher WD, Cates W Jr. Self reported pelvic inflammatory disease in the U.S., 1988. JAMA 1991;266:2570–2573.
Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol 1990;162:639–644.
Centers for Disease Control. Pelvic inflammatory disease: Guidelines for prevention and management. MMWR 1991;40:1–25.
Washington AE, Aral SO, Wolner-Hanssen P, Grimes DA, Holmes KK. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991;266:2581–2586.
Scholes D, Daling JR, Stergachis A. Current cigarette smoking and risk of acute pelvic inflammatory disease. Am J Public Health 1992;82:1352–1355.
Rolfs RT. “Think PID” New directions in prevention and management of PID. Sex Transm Dis 1991;18:131–132.
Hillis SD, Joesoef R, Marchbank PA, Wasserheit JN, Cates W Jr. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993;168:1503–1509.
Aral SO, Soskolne V, Joesoef RM, O’Reilly KR. Sex partner selection as risk factor for STD: Clustering of risky modes. Sex Transm Dis 1991;18: 10–17.
Rein MF. Urethritis, in Mandell GL, Douglas RG, Bennett JE (eds): Principles and Practice of Infectious Disease, 3rd ed. New York, Churchill Livingstone, Inc., 1990, pp 942–952.
Wølner-Hanssen P, Eschenbach DA, Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990;263:54–59.
Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: New results from the Women’s Health Study. Obstet Gynecol 1988;72:1–6.
Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984;251:2822–2824.
Kelaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982;248:184–187.
Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991;266:2574–2580.
Kamwendo F, Johansson E, Moi H, Forslin L, Danielsson D. Gonorrhea, genital chlamydial infection, and nonspecific urethritis in male partners of women hospitalized and treated for acute pelvic inflammatory disease. Sex Transm Dis 1993;20:143–146.
Stamm WE, Koutsky LA, Benedetti JK, et al. Chlamydia trachomatis urethral infections in men. Ann Int Med 1984;100:47–51.
Morton WE, Horton HB, Baker HW. Effects of socioeconomic status on incidences of three sexually transmitted diseases. Sex Transm Dis 1979;6: 206–210.
Centers for Disease Control. Condoms for prevention of sexually transmitted diseases. MMWR 1988;37:133–137.
Darrow WW. Condom use and use-effectiveness in high-risk populations. Sex Transm Dis 1989;16:157–160.
Quinn RW, O’Reilly KR, Khaw M. Gonococcal infections in women attending the venereal disease clinic of the Nashville Davidson County Metropolitan Health Department, 1984. South Med J 1988;81:851–854.
Dan B. Sex and the singles’ whirl: The quantum dynamics of Hepatitis B. JAMA 1986;256:1344.
Alter MJ, Ahtone J, Weisfuse I, Starko K, Vacalis TD, Maynard JE. Hepatitis B virus transmission between heterosexuals. JAMA 1986;256:1307–1310.
Pessione F, Dolivo M, Casin I, et al. Sexual behavior and smoking: Risk factor for urethritis in men. Sex Transm Dis 1988;15:119–122.
Stamm WE, Cole B. Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis 1986;13:163–165.
Schachter J, Stoner E, Moncada J. Screening for chlaymdia infections in women attending family planning clinics. West J Med 1983;138:375–379.
Greenberg JB, Magder L, Aral SO. Age at first coitus: A marker for risky sexual behavior in women. Sex Transm Dis 1992;19:331–334.
Seidman SN, Mosher WD, Aral SO. Women with multiple sexual partners: USA, 1988. Am J Pub Health 1992;82:1388–1394.
Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutal RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis in women attending family planning clinics. JAMA 1986;255:1730–1734.
D’Costa LJ, Plummer FA, Bowner I, et al. Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis 1985;12: 64–67.
Lee NC, Rubin GL, Grimes DA. Measures of sexual behavior and the risk of pelvic inflammatory disease. Obstet Gynecol 1991;77:425–430.
Pederson AHB, Bonin P. Screening females for asymptomatic gonorrhea infection. Northwest J Med 1971;70:255–261.
Johnson BA, Poses RM, Fortner CA, Meier FA, Dalton HP. Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA 1990;264:3161–3170.
Cates W Jr, Rolfs RT Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update. Epidemiol Rev 1990;12:199–220.
Aral SO, Holmes KK. Sexually transmitted diseases in the AIDS era. Sci Am 1991;264:62–69.
Aral SO, Holmes KK. Descriptive epidemiology of sexual behavior and sexually transmitted diseases, in Holmes KK, Mardh, P-A, Sparling PF, et al. (eds): Sexually Transmitted Diseases, 2nd ed. New York: McGraw-Hill 1990: 19–36.
Handsfield HH, Rice RJ, Roberts MC, Holmes KK. Localized outbreak of penicillinase-producing Neisseria gonorrhoeae. JAMA 1989;261: 2357–2361.
McCutchan JA. Epidemiology of venereal urethritis: Comparison of Gonorrhea and nongonococcal urethritis. Rev Infect Dis 1984;6:669.
Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983;250:3205.
Cates W, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771–1781.
Katz BP, Caine VA, Jones RB. Estimation of transmission probabilities for chlamydial infection, in Bowie WR, Caldwell HD, Jones RB, et al. (eds): Chlamydial Infections. Cambridge, Cambridge University Press, 1990, pp 567–570.
Grimes DA, Cates W. Family planning and sexually transmitted diseases, in Holmes KK, Mardh P-A, Sparling PF, et al. (eds): Sexually Transmitted Diseases, 2nd ed. New York, McGraw-Hill, 1990, pp 1087–1094.
Instructions for condom use. Population Reports Series L:6,XIV:3,Pl-274. Baltimore, MD, The Johns Hopkins University, 1986.
Stone KR, Grimes DA, Magder LS. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986;155:180–188.
Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988;158:518–523.
Rosenberg MJ, Rojanapithayakorn W, Feldblum PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis: A comparative clinical trial. JAMA 1987:2308–2312.
Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984;251:2822.
Quinn RW, O’Reilly KR. Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee. Sex Transm Dis 1985;12:29.
Bradbeer CS, This RN, Tan T, Thirumoorthy T. Prophylaxis against infection in Singaporean prostitutes. Genitourin Med 1988;64:52–53.
Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN. Factors related to genital chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988;128:298–308.
Judson FN, Ehret JM, Bolin GF, Levin MJ, Rietmeijer CAM. Unpublished data, 1992.
Hooton TM, Hillier S, Johnson C, Roberts PL, Stamm WE. Escherichia coli bacteriuria and contraceptive method. JAMA 1991;265:64–69.
Hooton TM, Fihn SD, Johnson C, Roberts PL, Stamm WE. Association between bacterial vaginosis and acute cystitis in women using diaphragms. Arch Intern Med 1989;149:1932–1936.
Hillier S, Hooton TM, Personal communication.
Shafer M-A, Beck A, Blain B, Dole P, Irwin CE Jr, Sweet R, Schachter J. Chlamydia trachomatis: Important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr 1984;104: 141–146.
Washington AE, Gove GF, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease: A word of caution about protection. JAMA 1985;253:2246–2250.
Louv WC, Austin H, Perlman J, Alexander WJ. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989;160:396.
Ripa KT, Svensson L, Mardh P-A, et al. Chlamydia trachomatis cervicitis in gynecologic outpatients. Obstet Gynecol 1978;52:698–702.
Lidegaard D, Helm P. Pelvic inflammatory disease: The influence of contraceptive, sexual, and social life events. Contraception 1990;41:475–483.
Eschenbach D, Stevens C, Critchlow C, Holmes KK. Epidemiology of acute PID. Presented at the International Society of STD Research 9th International Meeting. Banff, Alberta, Canada, Oct. 6-9, 1991.
Wølner-Hanssen P, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990;263:1936–1941.
Scholes D, Daling JR, Stergachis A, Weiss NS, Wang SP, Grayston JT. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol 1993;81:601–606.
Daling JR, Sherman KJ, Weisss NS. Risk factors for condyloma acuminatum in women. Sex Transm Dis 1986;13:16–18.
Kivijarvi A, Jarvinen H, Gronroos M. Microbiology of vaginitis associated with the intrauterine contraceptive device. Br J Obstet Gynecol 1984;91: 917–923.
Platt R, Rice PA, McMcormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983;250:3205–3209.
Heinonnen PK, Teisala K, Punnonen R, Miettinen A, Lehtinen M, Paavonen J. Anatomic sites of upper genital tract infection. Obstet Gynecol 1985;66: 384–390.
Cleary RE, Jones RB. Recovery of Chlamydia trachomatis from the en-dometrium in infertile women with serum antichlamydial antibodies. Fertil Steril 1985;44:233.
Spence MR, et al. A comparative evaluation of vaginal, cervical, and peritoneal flora in normal health females. Sex Transm Dis 1981;9:762.
Rank RG, Sanders MM. Ascending genital tract infection as a common consequence of vaginal inoculations with the guinea pig inclusion conjunctivitis agent in normal guinea pigs, in Bowie WR, Caldwell HD, Jones RP, et al. (eds): Chlamydial Infections. Proceedings of the Seventh International Symposium in Human Chlamydial Infections. Cambridge, Cambridge Univ. Press, 1990, pp 249–252.
Odeblad E. The functional structure of human cervical mucus. Acta Obstet Gynecol Scand 1968;47(suppl 1):39.
Cramer DW, Goldman MB, Schiff I, et al. The relationship of tubal infertility to barrier-method and oral contraceptives use. JAMA 1987;257:2446–2450.
Cates W, Joesoef MR, Goldman MB. Atypical pelvic inflammatory disease: Can we identify clinical predictors? Am J Obstet Gynecol 1993;169:341–346.
Li D-K, Daling JR, Stergachis AS, Chu J, Weiss NS. Prior condom use and the risk of tubal pregnancy. Am J Public Health 1990;80:964–966.
Duncan ME, Tibaux G, Pelzer A, et al. First coitus before menarche and risk of sexually transmitted disease. Lancet 1990;335:338–340.
Rolfs RT, Galaid EI, Zaidi AA. Epidemiology of pelvic inflammatory disease: Trends in hospitalizations and office visits, 1979-1988. Am J Obstet Gynecol 1992;166:983–990.
Forrest KA, Washington AE, Daling JR, Sweet RL. Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc 1989;81:159–165.
WHO Scientific Group. The mechanism of action, safety, and efficacy of intrauterine devices. WHO Tech Rep Ser 753; 1987.
Sweet RL, Blankfort-Doyle M, Robbie MO, Schacter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986;255:2062–2064.
Eschenbach DA, Harnisch JP, Holmes KK. Pathogenesis of acute pelvic inflammatory disease: Role of contraception and other risk factors. Am J Obstet Gynecol 1977;128:838–850.
Masters W, Johnson V. Human Sexual Response. Boston, Little Brown, 1966, p116.
Bengtsson LP. Hormonal effects on human myometrial activity. Vitam Horm 1973;31:257.
Filer RB, Wu CH. Coitus during menses: Its effect on endometriosis and pelvic inflammatory disease. J Reprod Med 1989;34:887–890.
Senanayake P, Kramer DG. Contraception and the etiology of pelvic inflammatory disease: New perspectives. Am J Obstet Gynecol 1980;138:852–860.
Svensson L, Weström L, Mardh P. Contraceptives and acute salpingitis. JAMA 1984;251:2553.
Rubin GL, Ory HW, Layde PM. Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol 1982;144:630.
Targum SD, Wright NH. Association of the intrauterine device and pelvic inflammatory disease: A retrospective pilot study. Am J Epidemiol 1974; 100:262–271.
Faulkner WL, Ory HW. Intrauterine devices and pelvic inflammatory disease. JAMA 1976;235:1851–1853.
Ryden G, Fahraeus L, Molin L, et al. Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhea? Contraception 1979;20:149–157.
Noonan AS, Adams JB. Gonorrhea screening in an urban hospital family planning program. Am J Public Health 1974;64:700–704.
Wølner-Hanssen P. Oral contraceptive use modifies the manifestations of pelvic inflammatory disease. Br J Obstet Gynecol 1986;93:619–624.
Wølner-Hanssen P, Svensson L, Mardh P-H, et al. Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet and Gynecol 1985;66:233–238.
Oriel JD, Powis PA, Reeve P, et al. Chlamydial infections of the cervix. Br J Vener Dis 1974;50:11–16.
Oriel JD, Johnson AL, Barlow D, et al. Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis 1978:52:698–702.
Arya OP, Mallison H, Goddard AD. Epidemiological and clinical correlates of chlamydial infection of the cervix. Br J Vener Dis 1981;57:118–124.
Wølner-Hanssen P, Kiviat NB, Holmes KK. Atypical pelvic inflammatory disease: Subacute, chronic, or subclinical upper genital tract infection in women, in Holmes KK, Mardh P-A, Sparling PF, et al. (eds): Sexually Transmitted Diseases, 2nd ed. New York, McGraw-Hill, 1990, pp 615–620.
Washington AE, Gore S, Schachter J, et al. Oral contraceptives, Chlamydia trachomatis infections and pelvic inflammatory diseases. JAMA 1985; 253:2246–2250.
Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138:880–892.
Buchan H, Villard-Mackintosh L, Vessey M, Yeates D, McPherson K. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol 1990;97:780–788.
Scholes D, Daling JR, Stergachis AS. Cigarette smoking and risk of pelvic inflammatory disease. Am J Epidemiol 1990;132:759.
Fullilove RE, Fullilove MT, Bowser BP, Gross SA. Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, Calif. JAMA 1990;263:851–855.
Kronmal RA, Whitney CW, Mumford SD. The intrauterine device and pelvic inflammatory disease: The Woman’s Health Study reanalyzed. J Clin Epidemiol 1991;44:109–122.
DATTA panelists. Diagnostic and therapeutic technology assessment. Intrauterine devices. JAMA 1989;261:2127–2130.
Grimes DA. The intrauterine device, pelvic inflammatory disease, and infertility: The confusion between hypothesis and knowledge [comment]. Fertil Steril 1992;58:670–673.
Chi I. What we have learned from recent IUD studies: a researcher’s perspective. Contraception 1993;48:81–108.
Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185–192.
Chow W-H, Daling JR, Weiss NS, et al. Maternal cigarette smoking and tubal pregnancy. Obstet Gynecol 1988;71:167–170.
Phipps WR, Cramer DW, Schiff I, et al. The association between smoking and female infertility as influenced by cause of the infertility. Fertil Steril 1987; 48:377–382.
Harlap S, Kost K, Forrest JD. Preventing Pregnancy, Protecting Health: A New Look at Birth Control Choices in the United States. New York, The Alan Guttmacher Institute, 1991.
Miettinen A, Heinonnen PK, Teisala K, Hakkarainen K, Punnonen R. Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis 1990;17:10–14.
Chow JM, Yonekura L, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy: A matched-pair, case-control study. JAMA 1990;263:3164–3167.
Chow W-H, Daling JR, Weiss NS, Moore DE, Soderstrom R. Vaginal douching as a potential risk factor for tubal ectopic pregnancy. Am J Obstet Gynecol 1985;153:727–729.
Jones RB, Ardery BR, Hui SL, Cleary RE. Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility. Fertil Steril 1982;38:553–558.
Moore RE, Spandoni LR, Foy HM, Wang S-P, Daling JR. Recovery of Chlamydia trachomatis in infertility due to distal tube disease. Lancet 1982;2:574–577.
Svensson L, Mardh P-A, Ahlgren M, Nordenskjold F. Ectopic pregnancy and antibodies to Chlamydia trachomatis. Fertil Steril 1985;44:313–317.
Aral SO, Cates W. The multiple dimensions of sexual behavior as risk factor for sexually transmitted disease: The sexually experienced are not necessarily sexually active. Sex Trans Dis 1989;12:173–177.
Cates W Jr, Wasserheit JN. Gonorrhea, chlamydia, and pelvic inflammatory disease: A review of the recent literature. Curr Opin Infect Dis 1992.
Seidman SN, Mosher WD, Aral SO. Predictors of high-risk behavior in unmarried American women: Adolescent environment as risk factor. J Adolesc Health 1994;15:126–132.
Seidman SN, Rieder RO. A review of sexual behavior in the United States. Am J Psychiatry 1994;151:330–341.
Rolfs RT. Personal communication, 1992.
Aral SO. Sexual behavior and risk for sexually transmitted infections. STD Bull 1991;10:3–10.
Spence MR, Adler J, McLellan R. Pelvic inflammatory disease in the adolescent. J Adolesc Health Care 1990;11:304–309.
Seidman SN, Aral SO. Sub-population differentials in STD transmission (letter). Am J Pub Health 1992;82:1297.
Wasserheit JN. STD research strategies. Presented at International STD Research Workship: Priorities for the Agency for International Development in the 1990s. Centers for Disease Control, Atlanta, Georgia, July 23-25, 1991.
McCormack WM. Pelvic inflammatory disease. N Engl J Med 1994;330: 115–119.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Seidman, S.N., Aral, S.O. (1997). Behavioral Aspects of Pelvic Inflammatory Disease. In: Landers, D.V., Sweet, R.L. (eds) Pelvic Inflammatory Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-0671-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0671-2_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6863-5
Online ISBN: 978-1-4612-0671-2
eBook Packages: Springer Book Archive